Epibiotech Co., Ltd. (XKON:446440)
13,000
+210 (1.64%)
At close: Jul 31, 2026
13.04% (1Y)
| Market Cap | 29.99B +13.0% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35 |
| Open | 13,000 |
| Previous Close | 12,790 |
| Day's Range | 13,000 - 13,000 |
| 52-Week Range | 10,500 - 20,900 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |